Strong Momentum Continues in 2021
- March 1, 2021
An Important Message to Our Clients From Your Healthcare Investment Banking Team
Oppenheimer Healthcare had a strong start to 2021, raising over $3.4B in financings year-to-date as well as closing a sell side M&A transaction.
As part of our commitment to clients, we are available at any time. Please feel free to reach out to your investment banking representative.
Managing Director, Head of Healthcare ECM
This document is for discussion purposes only and does not constitute advice of any kind, including tax, accounting, legal or regulatory advice, and Oppenheimer & Co. Inc. Is not and does not hold itself out to be an advisor as to tax, accounting, legal or regulatory matters.
The information contained herein was obtained from public sources and was relied upon by Oppenheimer & Co. Inc. Without assuming responsibility for independent verification as to the accuracy or completeness of such information. No representation or warranty, express or implied, is made as to the accuracy or completeness of such information and nothing contained herein is, or shall be relied upon as, a representation or warranty, whether as to the past or the future. Oppenheimer & Co. Inc. Assumes no obligation to update or otherwise revise these materials.
Oppenheimer & Co. Inc.’s research department is required to be independent from its investment banking department, and its research analysts may hold and make statements or investment recommendations that differ from the views of its investment bankers. Further, pursuant to applicable law, Oppenheimer & Co. Inc. Is (among other things) precluded from offering favorable research, a specific rating or a specific price target, or threaten to change research, a rating or a price target, as consideration or inducement for the receipt of business or compensation.